TrialDiabetes care2026

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.

Johannes F E Mann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.